140 related articles for article (PubMed ID: 17095022)
1. Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.
Gotfryd K; Owczarek S; Hoffmann K; Klementiev B; Nau H; Berezin V; Bock E; Walmod PS
Neuropharmacology; 2007 Mar; 52(3):764-78. PubMed ID: 17095022
[TBL] [Abstract][Full Text] [Related]
2. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
Andrews JE; Ebron-McCoy MT; Bojic U; Nau H; Kavlock RJ
Teratology; 1997 May; 55(5):314-8. PubMed ID: 9261925
[TBL] [Abstract][Full Text] [Related]
4. Differential enantioselective effects of pentyl-4-yn-valproate on spatial learning in the rat, and neurite outgrowth and cyclin D3 expression in vitro.
O'Loinsigh ED; Gherardini LM; Gallagher HC; Foley AG; Murphy KJ; Regan CM
J Neurochem; 2004 Jan; 88(2):370-9. PubMed ID: 14690525
[TBL] [Abstract][Full Text] [Related]
5. Pentyl-4-yn-valproic acid reverses age-associated memory impairment in the Wistar rat.
Foley AG; Gallagher HC; Murphy KJ; Regan CM
Neurobiol Aging; 2004 Apr; 25(4):539-46. PubMed ID: 15013575
[TBL] [Abstract][Full Text] [Related]
6. S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.
Eikel D; Hoffmann K; Zoll K; Lampen A; Nau H
Drug Metab Dispos; 2006 Apr; 34(4):612-20. PubMed ID: 16415118
[TBL] [Abstract][Full Text] [Related]
7. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.
Walmod PS; Foley A; Berezin A; Ellerbeck U; Nau H; Bock E; Berezin V
Cell Motil Cytoskeleton; 1998; 40(3):220-37. PubMed ID: 9678666
[TBL] [Abstract][Full Text] [Related]
8. Pentyl-4-yn-valproic acid enhances both spatial and avoidance learning, and attenuates age-related NCAM-mediated neuroplastic decline within the rat medial temporal lobe.
Murphy KJ; Fox GB; Foley AG; Gallagher HC; O'Connell A; Griffin AM; Nau H; Regan CM
J Neurochem; 2001 Aug; 78(4):704-14. PubMed ID: 11520891
[TBL] [Abstract][Full Text] [Related]
9. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
[TBL] [Abstract][Full Text] [Related]
10. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
[TBL] [Abstract][Full Text] [Related]
11. Effects of P2, a peptide derived from a homophilic binding site in the neural cell adhesion molecule on learning and memory in rats.
Rizhova L; Klementiev B; Cambon K; Venero C; Sandi C; Vershinina E; Vaudano E; Berezin V; Bock E
Neuroscience; 2007 Nov; 149(4):931-42. PubMed ID: 17949921
[TBL] [Abstract][Full Text] [Related]
12. Prediction of teratogenic potency of valproate analogues using cerebellar aggregation cultures.
Maar TE; Ellerbeck U; Bock E; Nau H; Schousboe A; Berezin V
Toxicology; 1997 Jan; 116(1-3):159-68. PubMed ID: 9020517
[TBL] [Abstract][Full Text] [Related]
13. Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.
Andrews JE; Ebron-McCoy M; Bojic U; Nau H; Kavlock RJ
Toxicol Appl Pharmacol; 1995 Jun; 132(2):310-6. PubMed ID: 7785058
[TBL] [Abstract][Full Text] [Related]
14. Valproate decreases inositol biosynthesis.
Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
[TBL] [Abstract][Full Text] [Related]
15. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Foley AG; Cassidy AW; Regan CM
Eur J Pharmacol; 2014 Mar; 727():80-6. PubMed ID: 24486700
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potency.
Bacon CL; Berezin V; Bode G; Bock E; Bojic U; Doherty P; Ehlers K; Ellerbeck U; Julien P; Kawa A; Maar TE; Nau H; Pirovano R; Regan CM; Schousboe A; Spezia F; Walsh FS; Williams EJ
Toxicol In Vitro; 1998 Apr; 12(2):101-9. PubMed ID: 20654391
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drug.
Sobol E; Yagen B; Steve White H; Wilcox KS; Lamb JG; Pappo O; Wlodarczyk BJ; Finnell RH; Bialer M
Neuropharmacology; 2006 Sep; 51(4):933-46. PubMed ID: 16890251
[TBL] [Abstract][Full Text] [Related]
18. The enantiomers of the valproic acid analogue 2-n-propyl-4-pentynoic acid (4-yn-VPA): asymmetric synthesis and highly stereoselective teratogenicity in mice.
Hauck RS; Nau H
Pharm Res; 1992 Jul; 9(7):850-5. PubMed ID: 1437995
[TBL] [Abstract][Full Text] [Related]
19. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680
[TBL] [Abstract][Full Text] [Related]
20. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
